Cylera
About
Healthcare-specific IoMT and medical device security platform — founded by clinical and security professionals, purpose-built for hospital IT and biomedical engineering teams. Cylera Platform provides passive device discovery, vulnerability assessment, and behavioral threat detection specifically optimized for clinical IoT including infusion pumps, imaging systems, and patient monitoring. Integrates with CMMS (Nuvolo, ServiceNow, Accruent) for unified asset management across biomedical and IT. S...
Details
VenSearch Intelligence
Ideal Customer
- Cylera specifically targets mid-to-large enterprise healthcare organizations, with Quadrant Knowledge Solutions noting the platform supports hospitals with 150 or more beds and larger networks managing multiple facilities.
- Ideal customers are complex, multi-site health systems and NHS trusts with diverse connected medical device estates — such as St. Luke's University Health Network (300+ facilities) or large NHS trusts managing 10,000+ connected devices.
Key Differentiators
- Cylera's core differentiator is its fully passive, agentless approach to medical device discovery and security — using patented IoT Device Emulation™ technology to create 'digital twins' of devices, enabling real-time vulnerability analysis and behavioral anomaly detection without any active scanning that could disrupt patient-critical equipment.
- Their patented Adaptive Data Type Analysis™ delivers high-fidelity device identification, including zero-day devices and protocols, which they claim outperforms generic IT security tools.
Industries Served
- Cylera is exclusively focused on the healthcare industry, serving hospitals, health systems, NHS trusts, and regional healthcare networks.
- Their platform addresses clinical IoT (IoMT), medical devices, operational technology (OT), building management systems (BMS), and enterprise IoT within hospital environments.
Service Coverage
- Cylera operates globally with its primary headquarters in New York, NY and regional offices throughout the US and the UK, including a notable presence in Cheltenham, England, and having expanded into Madrid, Spain.
- The company serves healthcare networks across the United States and the United Kingdom, with named customers including St. Luke's University Health Network (300+ facilities), NHS trusts such as Dartford and Gravesham, University Hospitals of Morecambe Bay, and NHS National Services Scotland (a disclosed £2.3M contract).
Partnerships
- Cylera has a formal technology alliance with Cisco, integrating with Cisco ISE (via pxGrid), Cisco DNA Center/Catalyst Center, and Cisco Prime for NAC, network segmentation, and asset intelligence sharing.
- Additional platform integrations include ServiceNow (ITSM/CMDB for ticket creation and device inventory hydration), Splunk (SIEM threat and risk data feeds), Check Point (firewall policy enforcement), and IBM QRadar (SIEM).
Company Size & Ownership
- Cylera was founded in 2017 by Timur Ozekcin, Sean Abraham, and Paul Bakoyiannis, and spent approximately three years in development before generating revenue starting in 2020.
- The company currently employs approximately 36–37 people as of mid-2026, placing it firmly in the small-company category.
Compliance & Certifications
- Cylera's platform is aligned with the NIST Cybersecurity Framework and ISO 27001, and is designed to support customers' compliance with HIPAA, UK GDPR, the UK Data Protection Act (DPA), the NHS Data Security and Protection Toolkit (DSPT), and the UK Cyber Assessment Framework (CAF).
- Cylera holds patented technologies (including Adaptive Data Type Analysis™ and IoT Device Emulation™) and has earned external recognition for its security capabilities — winning Best Threat Detection at the 2023 Fortress Cybersecurity Awards and being named a top technology leader by Quadrant Knowledge Solutions in the SPARK Matrix for Connected Medical Device Security Solutions (Q4 2023).
Compiled from public sources by VenSearch · Last researched October 14, 2026
Offerings
1 offeringCylera Platform
Passive IoMT security and asset intelligence for healthcare — discovers and classifies medical devices, BMS systems, and clinical IoT without active scanning. Risk scoring combines CVE severity with clinical context (is this device life-critical?) to prioritize remediation. Biomedical engineering integration connects device security data with CMMS work orders for unified device lifecycle management.
Considering Cylera?
Our team will work with you to determine if Cylera is the right fit for your organization. From research and assessment through procurement negotiation and ongoing vendor management — we handle the entire process at no cost to you.